Remove Drug Development Remove Health Technology Remove Trends
article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

article thumbnail

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” They can view historic data and forecast future trends.

article thumbnail

How Digital Health improves patient experiences in Alzheimer’s care

Digital Health Global

Despite a history of drug development failures in the field, recent work provides reason for optimism, showing a possible therapeutic arsenal to limit disease progression at an early stage.

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

Key Trends Shaping Valuations: Consolidation and M&A: Larger companies may acquire smaller, innovative startups to expand their product portfolios and accelerate growth. By closely monitoring these trends and adapting to the evolving landscape, HealthTech companies can position themselves for long-term success and significant valuations.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

article thumbnail

Digital Health v HealthTech: What is the difference?

Lloyd Price

Goal: Empower individuals to manage their health, prevent diseases, and access healthcare services efficiently. Healthtech Focus: Broader term encompassing the use of technology to improve the overall healthcare delivery system. This includes telehealth, mobile health apps, and wearable devices. How is healthtech evolving?